Escalon Medical Corp. (Escalon) operates in the healthcare market. The Company is engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. The Company operates in two segments: Sonomed-Escalon and Escalon Medical Corp. The Sonomed-Escalon segment consists of Sonomed, EMI and Trek, all of which are engaged in the development and sale of ophthalmic medical devices. The systems are of four types: A-Scans, B-Scans, High Frequency B-Scans (UBMs) and pachymeters. The A-Scan provides information about the internal structure of the eye. The B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. The UBM is an ultrasound device, designed to provide detailed information about the anterior segment of the eye. The Color/Fluorescein Angiography (CFA) Digital Imaging Systems are designed for ophthalmology.
|Headquarters||Suite 200, 100 Church Street|
ARDMORE, PA, United States 19003
|Chairman of the Board||Richard DePiano|
|President, General Counsel, Director||Richard DePiano|
|Chief Financial Officer||Robert O'Connor|
|Chief Operating Officer||Mark Wallace|
|Independent Director||Fred Choate|
|Shares Out.||7.5M||Book Value||$0.46|
|Annual Dividend Rate||$0.00||Price/Sales (TTM)||1.0|
|Ex-Div Date||1/1/01||P/Cash Flow (TTM)||--|
|Pay Date||1/1/01||Operating Margin||-6.60%|
*GAAP = prior to non-GAAP analyst adjusted earnings.